As the global cancer burden intensifies, the world’s attention has shifted towards countries capable of driving both innovation and affordability in cancer care. China has rapidly evolved from a follower to a trailblazer in oncology, leveraging its massive clinical infrastructure, government-backed research ecosystem, and growing biotech sector to revolutionize cancer treatment at a global scale.